Durability of Immune Response After COVID-19 Booster Vaccination

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 15, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.31778?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=091522

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: Reduction in antibody levels five months after the third BioNTech/Pfizer COVID-19 vaccine dose among nearly 4,000 health care workers in Israel was slower than after the second, while Omicron’s neutralizing response was lower compared with other variants of concern. Peak antibody levels after the third dose were associated with Omicron infection.

Authors: Mayan Gilboa, M.D., of the Sheba Medical Center in Ramat Gan, Israel, is the corresponding author.

 

(doi:10.1001/jamanetworkopen.2022.31778)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.